Korean drug firms’ cash ratio falls in 2012

Korea's overall cash asset ratio deteriorated in 2012 from a year earlier due to the government’s forced price cut for drugs and other medical products covered by national health insurance, a local pharmaceutical portal Yakup.com said Monday.

The average ratio of current assets to current liabilities, a key barometer of a firm’s market liquidity and ability to meet creditor's demands, droppe...